With quinine-based drugs, traditionally sought to treat malaria, failing to contain the disease anymore, scientists of the Central Institute of Medicinal and Aromatic Plants (cimap), based in Lucknow, have now developed a new drug in their war against the disease.
Certain strains of the malarial parasite have developed resistance to the quinine-based drugs. The new drug involves the conversion of arteminisinic acid into artemisinin, till now deemed unachievable in India; the drug, while available in China and Burma, was not available here.
Artemisinin is an anti-malarial compound -- active against the malarial parasite -- derived from the plant Artemisia annua, which is now being cultivated in the Kashmir valley. It has also been adapted to grow in the plains. A new liquid extraction technology developed by cimap led to the isolation of the artemisinin present in the flowers and leaves of the plant in low concentrations.
We are a voice to you; you have been a support to us. Together we build journalism that is independent, credible and fearless. You can further help us by making a donation. This will mean a lot for our ability to bring you news, perspectives and analysis from the ground so that we can make change together.